The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Psoriatic Arthritis (PsA) Treatment Market Research Report 2024
Synopsis
Psoriatic arthritis (PsA) is a chronic, inflammatory disease of the joints and entheses, where tendons and ligaments connect to bone. Like psoriasis, PsA is associated with related health conditions (comorbidities).
It can start at any age and may affect children. The disease often appears between ages 30 and 50. For many people, it starts about 10 years after psoriasis develops, but some develop PsA first or without ever developing or noticing psoriasis.
The global Psoriatic Arthritis (PsA) Treatment market was valued at US$ 9250 million in 2023 and is anticipated to reach US$ 16290 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis (PsA) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis (PsA) Treatment.
Report Scope
The Psoriatic Arthritis (PsA) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis (PsA) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis (PsA) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene
Segment by Type
Nonsteriodal Anti-inflammatory Drugs
Disease Modifying Antirheumatic Drugs
Biologics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis (PsA) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Psoriatic arthritis (PsA) is a chronic, inflammatory disease of the joints and entheses, where tendons and ligaments connect to bone. Like psoriasis, PsA is associated with related health conditions (comorbidities).
It can start at any age and may affect children. The disease often appears between ages 30 and 50. For many people, it starts about 10 years after psoriasis develops, but some develop PsA first or without ever developing or noticing psoriasis.
The global Psoriatic Arthritis (PsA) Treatment market was valued at US$ 9250 million in 2023 and is anticipated to reach US$ 16290 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis (PsA) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis (PsA) Treatment.
Report Scope
The Psoriatic Arthritis (PsA) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis (PsA) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis (PsA) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene
Segment by Type
Nonsteriodal Anti-inflammatory Drugs
Disease Modifying Antirheumatic Drugs
Biologics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis (PsA) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nonsteriodal Anti-inflammatory Drugs
1.2.3 Disease Modifying Antirheumatic Drugs
1.2.4 Biologics
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2019-2030)
2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Region
2.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics
2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends
2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2019-2024)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2023
3.5 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2025-2030)
5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
6.2 North America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024)
6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024)
7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024)
9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 UCB
11.5.1 UCB Company Detail
11.5.2 UCB Business Overview
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.5.5 UCB Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.8.5 Eli Lilly Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.10.5 AstraZeneca Recent Development
11.11 Celgene
11.11.1 Celgene Company Detail
11.11.2 Celgene Business Overview
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
11.11.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Nonsteriodal Anti-inflammatory Drugs
Table 3. Key Players of Disease Modifying Antirheumatic Drugs
Table 4. Key Players of Biologics
Table 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2019-2024)
Table 9. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2025-2030)
Table 11. Psoriatic Arthritis (PsA) Treatment Market Trends
Table 12. Psoriatic Arthritis (PsA) Treatment Market Drivers
Table 13. Psoriatic Arthritis (PsA) Treatment Market Challenges
Table 14. Psoriatic Arthritis (PsA) Treatment Market Restraints
Table 15. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players (2019-2024)
Table 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2023)
Table 18. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
Table 22. Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Psoriatic Arthritis (PsA) Treatment Product
Table 50. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Detail
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product
Table 55. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. AbbVie Company Detail
Table 58. AbbVie Business Overview
Table 59. AbbVie Psoriatic Arthritis (PsA) Treatment Product
Table 60. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 61. AbbVie Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Psoriatic Arthritis (PsA) Treatment Product
Table 65. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. UCB Company Detail
Table 68. UCB Business Overview
Table 69. UCB Psoriatic Arthritis (PsA) Treatment Product
Table 70. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 71. UCB Recent Development
Table 72. Roche Company Detail
Table 73. Roche Business Overview
Table 74. Roche Psoriatic Arthritis (PsA) Treatment Product
Table 75. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Bristol-Myers Squibb Company Detail
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product
Table 80. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Eli Lilly Company Detail
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product
Table 85. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. Amgen Company Detail
Table 88. Amgen Business Overview
Table 89. Amgen Psoriatic Arthritis (PsA) Treatment Product
Table 90. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. AstraZeneca Company Detail
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product
Table 95. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Celgene Company Detail
Table 98. Celgene Business Overview
Table 99. Celgene Psoriatic Arthritis (PsA) Treatment Product
Table 100. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2019-2024) & (US$ Million)
Table 101. Celgene Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2023 VS 2030
Figure 3. Nonsteriodal Anti-inflammatory Drugs Features
Figure 4. Disease Modifying Antirheumatic Drugs Features
Figure 5. Biologics Features
Figure 6. Global Psoriatic Arthritis (PsA) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 12. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2023
Figure 16. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2023
Figure 18. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2019-2030)
Figure 20. United States Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Country (2019-2030)
Figure 24. Germany Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Region (2019-2030)
Figure 32. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 47. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 48. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 50. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 53. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 54. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 56. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
